Parameters of antioxidant protection in multiple sclerosis

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

Volumn 109, Issue 7, 2009, Pages 53-56

  Krotenko, N V ^a   Alifirova, V M ^a   Ivanova, S A ^a  

^a NONE

Author keywords

Catalase; Demyelination; Glutathionreductase; Multiple sclerosis; Oxidant stress

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; MALONALDEHYDE;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPROTECTION; OXIDATIVE STRESS; RELAPSE; REMISSION;

ADOLESCENT; ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CATALASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PROGNOSIS; REMISSION INDUCTION; YOUNG ADULT;

EID: 77953454943     PISSN: 00444588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bredford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-354.
2. Gilgun-Sherki Y., Melamed E., Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 2004; 251: 261-268. (Pubitemid 38387142)
3. Kurtzke J.F. The diagnosis of multiple sclerosis, C.M. Poser eds. New York: Thieme-Stratton 1984; 3-13.
4. Smith K.J., Kapoor R., Felts P.A. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 1999; 9: 69-92. (Pubitemid 29056521)